about
Appetite stimulants for people with cystic fibrosisMeditative Movement as a Treatment for Pulmonary Dysfunction in Flight Attendants Exposed to Second-Hand Cigarette Smoke: Study Protocol for a Randomized Trial.The translational aspect of complementary and alternative medicine for cancer with particular emphasis on KampoGrowth and Development Symposium: Endotoxin, inflammation, and intestinal function in livestockRegulation of energy balance by inflammation: common theme in physiology and pathologyUnderstanding cachexia as a cancer metabolism syndromeThe central role of hypothalamic inflammation in the acute illness response and cachexiaThe role of the brown adipose tissue in β3-adrenergic receptor activation-induced sleep, metabolic and feeding responsesNeurobiology of food intake in health and disease.Obesity and leptin resistance: distinguishing cause from effect.Exercise training as treatment in cancer cachexia.Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms.Neuropeptides in the pathophysiology and treatment of cachexia.The effect of TNFα on food intake and central insulin sensitivity in ratsThe orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexiaHypothalamic inflammation: a double-edged sword to nutritional diseases.The hypothalamus in Alzheimer's disease: a Golgi and electron microscope study.Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexiaAgouti-related protein segments outside of the receptor binding core are required for enhanced short- and long-term feeding stimulationMissense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe diseaseA distinct brain pathway links viral RNA exposure to sickness behaviorAssociation of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.Hypothalamic activation is essential for endotoxemia-induced acute muscle wasting.When can nutritional therapy impact liver disease?Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation.Establishment and characterization of a novel murine model of pancreatic cancer cachexia.Lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNFα) blunt the response of Neuropeptide Y/Agouti-related peptide (NPY/AgRP) glucose inhibited (GI) neurons to decreased glucose.Hypothalamic Inflammation and Energy Balance Disruptions: Spotlight on Chemokines.Anorexia-cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma.Injection of β-amyloid into the hippocampus induces metabolic disturbances and involuntary weight loss which may be early indicators of Alzheimer's disease.The Way to the Liver Is Through the Pituitary Gland.Current status and future directions: equine pituitary pars intermedia dysfunction and equine metabolic syndrome.The habenula as a novel link between the homeostatic and hedonic pathways in cancer-associated weight loss: a pilot study.
P2860
Q24194798-54585D7E-536E-43B9-B89D-F93B62A7267BQ26752376-91D04494-FAA9-4358-B9D9-C4472783D724Q26795520-6EC40EEC-BBC9-4AAC-9A86-B7263EDFA3ACQ26828771-2F6EBDD5-F323-4732-98CC-2CB6788601C3Q26829584-36A22141-F3CC-4499-8902-70FCD72A4C41Q28069390-F01356D9-D350-45AE-9EAE-4FF9F54159ACQ28080648-56CF545D-28F9-43CB-B1D8-961286D9FC3CQ33680861-4F114529-A923-4B9C-9ADF-750C1F944096Q33825213-FEEC2D66-5E02-456D-BE31-66D953EF486AQ34259053-4187A146-3E5D-4A0E-81F2-481ED5DAC3DEQ34418882-32CEF737-D93F-4921-AAB0-1F459125ECC1Q34575896-69B89872-AC83-4B91-A71D-678E190BACC8Q34712204-F0646238-5A2E-4F54-99D8-394C8C905E45Q34743012-6FFBA41D-9E4C-42BA-A484-38EBCDCC0D6DQ35223982-98AFF474-B79F-4747-9A45-23902AB8DAA9Q35318592-62DA316C-3C1B-4CE9-BF90-A94135500788Q35404510-6E756864-6C89-4940-BE53-467410B66C66Q35599827-A5931CCA-2F7B-4D7D-A550-D9B47D73FC85Q35783645-7EE7F009-C396-44E5-B2D7-CCAF07781A71Q37078839-5CEAE58F-1D6F-4BAA-8DA7-733A42551DB3Q37110979-26C27EDD-122F-4013-B6C8-F28B60EF37CCQ37367645-4F55DBD7-611F-4A2A-98A2-6ED1E0F06F66Q37475891-47493055-5CB2-4EBB-8DEA-743120423CE2Q38245694-FB562FF6-3EBA-4B45-B71B-F82848D114B6Q38625302-01BC01A8-DC0E-4C76-BBB2-79193FF6E6D1Q38653925-97A3E356-E2F8-41B3-8F93-53A475DB553FQ39544008-5622478A-0AB5-4E4C-82FD-D19A320A6548Q41418798-0A05FB8E-F21E-4207-86D8-248F24C25233Q42290147-9EA5C52D-2E67-41D4-A126-EDDF87FDB4F4Q47190273-F16BAC00-512C-49EE-BFF6-0FB6B88B6F99Q50132184-8DC0A554-1FA9-41DE-A990-292119A80117Q51330358-9DA9FB91-2610-4270-B775-15BE6411F463Q52633234-8068D7EB-FEC5-46C5-ADF9-5C593F95B9D5
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hypothalamic mechanisms in cachexia.
@ast
Hypothalamic mechanisms in cachexia.
@en
Hypothalamic mechanisms in cachexia.
@nl
type
label
Hypothalamic mechanisms in cachexia.
@ast
Hypothalamic mechanisms in cachexia.
@en
Hypothalamic mechanisms in cachexia.
@nl
prefLabel
Hypothalamic mechanisms in cachexia.
@ast
Hypothalamic mechanisms in cachexia.
@en
Hypothalamic mechanisms in cachexia.
@nl
P2093
P2860
P1476
Hypothalamic mechanisms in cachexia.
@en
P2093
Aaron J Grossberg
Daniel L Marks
Jarrad M Scarlett
P2860
P304
P356
10.1016/J.PHYSBEH.2010.03.011
P407
P577
2010-03-25T00:00:00Z